nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—superior mesenteric artery—liver cancer	0.262	0.825	CbGeAlD
Propylthiouracil—DIO1—liver—liver cancer	0.0383	0.121	CbGeAlD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—EPT1—liver cancer	0.0374	0.0887	CbGpPWpGaD
Propylthiouracil—Allergic cutaneous angiitis—Sorafenib—liver cancer	0.0231	0.0886	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—EPT1—liver cancer	0.0227	0.0537	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFE2L2—liver cancer	0.0173	0.041	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—GPX3—liver cancer	0.0165	0.0392	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Sorafenib—liver cancer	0.0152	0.0583	CcSEcCtD
Propylthiouracil—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.015	0.0575	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—liver cancer	0.0145	0.0343	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—TAT—liver cancer	0.0117	0.0277	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—FST—liver cancer	0.0115	0.0273	CbGpPWpGaD
Propylthiouracil—DBH—liver—liver cancer	0.0113	0.0354	CbGeAlD
Propylthiouracil—Interstitial lung disease—Sorafenib—liver cancer	0.0104	0.0398	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—GPX3—liver cancer	0.01	0.0237	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—EPT1—liver cancer	0.00816	0.0193	CbGpPWpGaD
Propylthiouracil—Pigmentation disorder—Epirubicin—liver cancer	0.00813	0.0312	CcSEcCtD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—GLUL—liver cancer	0.00795	0.0188	CbGpPWpGaD
Propylthiouracil—Pigmentation disorder—Doxorubicin—liver cancer	0.00752	0.0289	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—TAT—liver cancer	0.00715	0.0169	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—GGT1—liver cancer	0.00704	0.0167	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—TAT—liver cancer	0.00672	0.0159	CbGpPWpGaD
Propylthiouracil—DBH—Monoamine Transport—MAPK14—liver cancer	0.00639	0.0151	CbGpPWpGaD
Propylthiouracil—Erythema nodosum—Epirubicin—liver cancer	0.00627	0.0241	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT4—liver cancer	0.00625	0.0148	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF2—liver cancer	0.0062	0.0147	CbGpPWpGaD
Propylthiouracil—MPO—liver—liver cancer	0.00602	0.019	CbGeAlD
Propylthiouracil—Hepatic failure—Sorafenib—liver cancer	0.00593	0.0228	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—liver cancer	0.0058	0.0223	CcSEcCtD
Propylthiouracil—Renal failure acute—Sorafenib—liver cancer	0.00577	0.0222	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL12B—liver cancer	0.00572	0.0136	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Sorafenib—liver cancer	0.00565	0.0217	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—HGF—liver cancer	0.00542	0.0128	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—MTHFR—liver cancer	0.00514	0.0122	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—JUN—liver cancer	0.00488	0.0116	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—GLUL—liver cancer	0.00486	0.0115	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—PSMA4—liver cancer	0.00457	0.0108	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—PSMD10—liver cancer	0.00457	0.0108	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—GLUL—liver cancer	0.00457	0.0108	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—GPX3—liver cancer	0.00453	0.0107	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—F2—liver cancer	0.00451	0.0107	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—GOT2—liver cancer	0.00444	0.0105	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Sorafenib—liver cancer	0.00403	0.0155	CcSEcCtD
Propylthiouracil—Jaundice—Sorafenib—liver cancer	0.004	0.0154	CcSEcCtD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—GOT1—liver cancer	0.00384	0.00909	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SERPINE1—liver cancer	0.00375	0.00889	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—ALB—liver cancer	0.00375	0.00887	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Sorafenib—liver cancer	0.00371	0.0142	CcSEcCtD
Propylthiouracil—Haemorrhage—Sorafenib—liver cancer	0.00369	0.0141	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—liver cancer	0.00363	0.0139	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—GPX3—liver cancer	0.0036	0.00854	CbGpPWpGaD
Propylthiouracil—Skin ulcer—Epirubicin—liver cancer	0.00348	0.0134	CcSEcCtD
Propylthiouracil—Neuritis—Doxorubicin—liver cancer	0.00336	0.0129	CcSEcCtD
Propylthiouracil—Ageusia—Epirubicin—liver cancer	0.00335	0.0129	CcSEcCtD
Propylthiouracil—Alopecia—Sorafenib—liver cancer	0.00326	0.0125	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—liver cancer	0.00322	0.0124	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—liver cancer	0.00322	0.0124	CcSEcCtD
Propylthiouracil—Dysgeusia—Sorafenib—liver cancer	0.00314	0.0121	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—liver cancer	0.0031	0.0119	CcSEcCtD
Propylthiouracil—DBH—Monoamine Transport—TNF—liver cancer	0.00304	0.00719	CbGpPWpGaD
Propylthiouracil—Liver injury—Doxorubicin—liver cancer	0.00298	0.0115	CcSEcCtD
Propylthiouracil—Leukopenia—Sorafenib—liver cancer	0.00287	0.011	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—MTHFR—liver cancer	0.00286	0.00678	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—PSMA4—liver cancer	0.00279	0.00661	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—PSMD10—liver cancer	0.00279	0.00661	CbGpPWpGaD
Propylthiouracil—Arthralgia—Sorafenib—liver cancer	0.00273	0.0105	CcSEcCtD
Propylthiouracil—Myalgia—Sorafenib—liver cancer	0.00273	0.0105	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—GOT2—liver cancer	0.00271	0.00643	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—PSMD10—liver cancer	0.00262	0.00622	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—PSMA4—liver cancer	0.00262	0.00622	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Sorafenib—liver cancer	0.00256	0.00984	CcSEcCtD
Propylthiouracil—TPO—Amino acid and derivative metabolism—GOT2—liver cancer	0.00255	0.00605	CbGpPWpGaD
Propylthiouracil—Aplastic anaemia—Epirubicin—liver cancer	0.00255	0.00978	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—GGT1—liver cancer	0.00253	0.00601	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—F2—liver cancer	0.00251	0.00595	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—UGDH—liver cancer	0.00241	0.00571	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—liver cancer	0.00241	0.0057	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00239	0.00916	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—liver cancer	0.00236	0.00905	CcSEcCtD
Propylthiouracil—DBH—Amino acid and derivative metabolism—GOT1—liver cancer	0.00234	0.00555	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—MTHFR—liver cancer	0.00233	0.00552	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Epirubicin—liver cancer	0.00231	0.00886	CcSEcCtD
Propylthiouracil—Dyspepsia—Sorafenib—liver cancer	0.00231	0.00885	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—EPT1—liver cancer	0.00227	0.00537	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—TNF—liver cancer	0.00221	0.00524	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—TGFB1—liver cancer	0.00221	0.00524	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—GOT1—liver cancer	0.0022	0.00522	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Epirubicin—liver cancer	0.00219	0.00841	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—liver cancer	0.00219	0.00518	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—GSTM1—liver cancer	0.00217	0.00515	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TAT—liver cancer	0.00215	0.00509	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Doxorubicin—liver cancer	0.00214	0.0082	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—liver cancer	0.00213	0.00819	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.00209	0.00495	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—liver cancer	0.00209	0.00801	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ALB—liver cancer	0.00209	0.00494	CbGpPWpGaD
Propylthiouracil—Urticaria—Sorafenib—liver cancer	0.00208	0.00799	CcSEcCtD
Propylthiouracil—Body temperature increased—Sorafenib—liver cancer	0.00207	0.00795	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—F2—liver cancer	0.00204	0.00484	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Doxorubicin—liver cancer	0.00203	0.00778	CcSEcCtD
Propylthiouracil—Renal failure acute—Doxorubicin—liver cancer	0.00197	0.00758	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00193	0.00741	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL6—liver cancer	0.00193	0.00456	CbGpPWpGaD
Propylthiouracil—Pruritus—Sorafenib—liver cancer	0.00185	0.00711	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—MTHFR—liver cancer	0.00185	0.00438	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—liver cancer	0.00184	0.00436	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL6—liver cancer	0.00178	0.00423	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—SERPINE1—liver cancer	0.0017	0.00403	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—ALB—liver cancer	0.0017	0.00402	CbGpPWpGaD
Propylthiouracil—Vomiting—Sorafenib—liver cancer	0.00167	0.00639	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—IL6—liver cancer	0.00166	0.00395	CbGpPWpGaD
Propylthiouracil—Rash—Sorafenib—liver cancer	0.00165	0.00634	CcSEcCtD
Propylthiouracil—Dermatitis—Sorafenib—liver cancer	0.00165	0.00633	CcSEcCtD
Propylthiouracil—Headache—Sorafenib—liver cancer	0.00164	0.0063	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—F2—liver cancer	0.00162	0.00385	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—TNF—liver cancer	0.00159	0.00377	CbGpPWpGaD
Propylthiouracil—Nausea—Sorafenib—liver cancer	0.00156	0.00597	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—liver cancer	0.00152	0.00582	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—liver cancer	0.00149	0.00571	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—liver cancer	0.00148	0.00568	CcSEcCtD
Propylthiouracil—DBH—Metabolism—UGDH—liver cancer	0.00147	0.00349	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GLUL—liver cancer	0.00146	0.00346	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CPT1B—liver cancer	0.00146	0.00346	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—liver cancer	0.00145	0.00344	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Epirubicin—liver cancer	0.00142	0.00544	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NR1H4—liver cancer	0.00141	0.00334	CbGpPWpGaD
Propylthiouracil—Drowsiness—Doxorubicin—liver cancer	0.0014	0.00539	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA3—liver cancer	0.00138	0.00328	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—EPT1—liver cancer	0.00138	0.00328	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UGDH—liver cancer	0.00138	0.00328	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—liver cancer	0.00138	0.00528	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL2—liver cancer	0.00138	0.00326	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Epirubicin—liver cancer	0.00137	0.00526	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—liver cancer	0.00137	0.00525	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—liver cancer	0.00136	0.00523	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—liver cancer	0.00136	0.00523	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—SERPINE1—liver cancer	0.00135	0.0032	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—ALB—liver cancer	0.00135	0.0032	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TAT—liver cancer	0.00131	0.00311	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Doxorubicin—liver cancer	0.00131	0.00503	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—liver cancer	0.00131	0.0031	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EPT1—liver cancer	0.0013	0.00308	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—liver cancer	0.00129	0.00305	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Doxorubicin—liver cancer	0.00127	0.00486	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA4—liver cancer	0.00127	0.003	CbGpPWpGaD
Propylthiouracil—Hepatitis—Doxorubicin—liver cancer	0.00126	0.00484	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—liver cancer	0.00126	0.00484	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA2—liver cancer	0.00123	0.00292	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TAT—liver cancer	0.00123	0.00292	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—TNF—liver cancer	0.00123	0.00292	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—liver cancer	0.0012	0.00462	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA1—liver cancer	0.00119	0.00282	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NAT2—liver cancer	0.00118	0.00279	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—liver cancer	0.00116	0.00446	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—liver cancer	0.00116	0.00275	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALDOB—liver cancer	0.00113	0.00267	CbGpPWpGaD
Propylthiouracil—Alopecia—Doxorubicin—liver cancer	0.00111	0.00428	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—liver cancer	0.00111	0.00262	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CRABP1—liver cancer	0.00108	0.00255	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Doxorubicin—liver cancer	0.00107	0.00412	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—liver cancer	0.00107	0.00254	CbGpPWpGaD
Propylthiouracil—Vertigo—Epirubicin—liver cancer	0.00107	0.00409	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—liver cancer	0.00106	0.00407	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—liver cancer	0.00101	0.00388	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—liver cancer	0.00101	0.00388	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TNF—liver cancer	0.001	0.00238	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—liver cancer	0.000994	0.00236	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—liver cancer	0.000986	0.00378	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—liver cancer	0.000982	0.00377	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—liver cancer	0.000968	0.00372	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Epirubicin—liver cancer	0.000948	0.00364	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HPGDS—liver cancer	0.000941	0.00223	CbGpPWpGaD
Propylthiouracil—Myalgia—Doxorubicin—liver cancer	0.000934	0.00359	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—liver cancer	0.000934	0.00359	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—liver cancer	0.000896	0.00344	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CPT1B—liver cancer	0.000892	0.00211	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GLUL—liver cancer	0.000892	0.00211	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—liver cancer	0.000887	0.0021	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—liver cancer	0.000884	0.00209	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000882	0.00338	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—liver cancer	0.000877	0.00337	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—liver cancer	0.000869	0.00334	CcSEcCtD
Propylthiouracil—Somnolence—Epirubicin—liver cancer	0.000861	0.0033	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NR1H4—liver cancer	0.00086	0.00204	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Epirubicin—liver cancer	0.000852	0.00327	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA3—liver cancer	0.000846	0.002	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PSMD10—liver cancer	0.000839	0.00199	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PSMA4—liver cancer	0.000839	0.00199	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CPT1B—liver cancer	0.000839	0.00199	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GLUL—liver cancer	0.000839	0.00199	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—liver cancer	0.00082	0.00194	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000816	0.00313	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GOT2—liver cancer	0.000816	0.00193	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL6—liver cancer	0.000809	0.00192	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NR1H4—liver cancer	0.000809	0.00192	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—liver cancer	0.000804	0.00309	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—TNF—liver cancer	0.000796	0.00189	CbGpPWpGaD
Propylthiouracil—Somnolence—Doxorubicin—liver cancer	0.000796	0.00306	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTA3—liver cancer	0.000795	0.00188	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Doxorubicin—liver cancer	0.000788	0.00303	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA4—liver cancer	0.000774	0.00183	CbGpPWpGaD
Propylthiouracil—Urticaria—Epirubicin—liver cancer	0.000769	0.00295	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2E1—liver cancer	0.000767	0.00182	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Epirubicin—liver cancer	0.000765	0.00294	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA2—liver cancer	0.000754	0.00179	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA1—liver cancer	0.000727	0.00172	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA4—liver cancer	0.000727	0.00172	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NAT2—liver cancer	0.000719	0.0017	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYCS—liver cancer	0.000718	0.0017	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—liver cancer	0.000712	0.00273	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTA2—liver cancer	0.000709	0.00168	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Doxorubicin—liver cancer	0.000708	0.00272	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GGT1—liver cancer	0.000704	0.00167	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GOT1—liver cancer	0.000704	0.00167	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—liver cancer	0.000697	0.00165	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALDOB—liver cancer	0.000689	0.00163	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—liver cancer	0.000685	0.00263	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTA1—liver cancer	0.000684	0.00162	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NAT2—liver cancer	0.000676	0.0016	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CRABP1—liver cancer	0.000658	0.00156	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALDOB—liver cancer	0.000648	0.00154	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—liver cancer	0.000643	0.00152	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—liver cancer	0.000634	0.00243	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTP1—liver cancer	0.000633	0.0015	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HMOX1—liver cancer	0.000624	0.00148	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CRABP1—liver cancer	0.000618	0.00147	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—liver cancer	0.000615	0.00236	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—liver cancer	0.00061	0.00234	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—liver cancer	0.00061	0.00234	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—liver cancer	0.000606	0.00233	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTM1—liver cancer	0.000581	0.00138	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—liver cancer	0.000575	0.00221	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HPGDS—liver cancer	0.000575	0.00136	CbGpPWpGaD
Propylthiouracil—Vomiting—Doxorubicin—liver cancer	0.000569	0.00219	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—liver cancer	0.000565	0.00217	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—liver cancer	0.000564	0.00217	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—liver cancer	0.000561	0.00215	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1A1—liver cancer	0.000551	0.00131	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPGDS—liver cancer	0.000541	0.00128	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—liver cancer	0.000532	0.00204	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTHFR—liver cancer	0.000514	0.00122	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PSMA4—liver cancer	0.000512	0.00121	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PSMD10—liver cancer	0.000512	0.00121	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPARA—liver cancer	0.000504	0.00119	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GOT2—liver cancer	0.000498	0.00118	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PSMD10—liver cancer	0.000482	0.00114	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PSMA4—liver cancer	0.000482	0.00114	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2E1—liver cancer	0.000469	0.00111	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GOT2—liver cancer	0.000469	0.00111	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2E1—liver cancer	0.000441	0.00104	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYCS—liver cancer	0.000439	0.00104	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—liver cancer	0.000432	0.00102	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GOT1—liver cancer	0.00043	0.00102	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GGT1—liver cancer	0.00043	0.00102	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPARG—liver cancer	0.000417	0.000987	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYCS—liver cancer	0.000412	0.000977	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GOT1—liver cancer	0.000405	0.000959	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GGT1—liver cancer	0.000405	0.000959	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTP1—liver cancer	0.000387	0.000916	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HMOX1—liver cancer	0.000381	0.000903	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—liver cancer	0.00038	0.000899	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALB—liver cancer	0.000375	0.000888	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTP1—liver cancer	0.000363	0.000861	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HMOX1—liver cancer	0.000358	0.000849	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM1—liver cancer	0.000355	0.000842	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1A1—liver cancer	0.000337	0.000798	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM1—liver cancer	0.000334	0.000791	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—liver cancer	0.000331	0.000784	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1A1—liver cancer	0.000317	0.00075	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTHFR—liver cancer	0.000314	0.000744	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARA—liver cancer	0.000308	0.00073	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTHFR—liver cancer	0.000295	0.000699	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPARA—liver cancer	0.00029	0.000686	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—liver cancer	0.000264	0.000625	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPARG—liver cancer	0.000255	0.000603	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—liver cancer	0.000248	0.000588	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPARG—liver cancer	0.000239	0.000567	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—liver cancer	0.000232	0.000549	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALB—liver cancer	0.000229	0.000542	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—liver cancer	0.000218	0.000517	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALB—liver cancer	0.000215	0.00051	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—liver cancer	0.000202	0.000479	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—liver cancer	0.000202	0.000478	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—liver cancer	0.00019	0.00045	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—liver cancer	0.000165	0.00039	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—liver cancer	0.000123	0.000292	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—liver cancer	0.000116	0.000274	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—liver cancer	0.000101	0.000238	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—liver cancer	9.46e-05	0.000224	CbGpPWpGaD
